Classification Term: 2412

Peptoid-peptide hybrids (ontology term: CHEMONTID:0001939)

Compounds containing a peptoid-peptide backbone, which consists alternating amino acid and n-substituted amino acids linked to each other by a peptide bond." []

found 8 associated metabolites at sub_class metabolite taxonomy ontology rank level.

Ancestor: Peptidomimetics

Child Taxonomies: Cyclosporins

[Sar9,Met(O2)11]-SUBSTANCE P

2-[({1-[6-amino-2-({[1-(2-amino-5-carbamimidamidopentanoyl)pyrrolidin-2-yl](hydroxy)methylidene}amino)hexanoyl]pyrrolidin-2-yl}(hydroxy)methylidene)amino]-N-[3-(C-hydroxycarbonimidoyl)-1-[(1-{[1-({[(1-{[1-(C-hydroxycarbonimidoyl)-3-methanesulphonylpropyl]-C-hydroxycarbonimidoyl}-3-methylbutyl)-C-hydroxycarbonimidoyl]methyl}(methyl)carbamoyl)-2-phenylethyl]-C-hydroxycarbonimidoyl}-2-phenylethyl)-C-hydroxycarbonimidoyl]propyl]pentanediimidic acid

C64H100N18O15S (1392.7335890000002)

D018377 - Neurotransmitter Agents > D015320 - Tachykinins [Sar9,Met(O2)11]-Substance P is a tachykinin NK1 receptor selective agonist.

Delapril

2-[N-(2,3-dihydro-1H-inden-2-yl)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanamido]acetic acid

C26H32N2O5 (452.2311102)

Delapril diacid

2-({1-[(carboxymethyl)(2,3-dihydro-1H-inden-2-yl)carbamoyl]ethyl}amino)-4-phenylbutanoic acid

C24H28N2O5 (424.1998118)

Dimethyl C7

2-{[hydroxy(5-hydroxy-3,4-dihydro-2H-pyrrol-2-yl)methylidene]amino}-N-(1-{[1-({[(1-{[1-(C-hydroxycarbonimidoyl)-3-(methylsulphanyl)propyl]-C-hydroxycarbonimidoyl}-3-methylbutyl)-C-hydroxycarbonimidoyl]methyl}(methyl)carbamoyl)-2-phenylethyl](methyl)carbamoyl}-2-phenylethyl)pentanediimidic acid

C43H61N9O9S (879.4312736)

Glycylsarcosine

2-(2-amino-N-methylacetamido)acetic acid

C5H10N2O3 (146.069139)

Napsagatran

2-(3-{[(1-carbamimidoylpiperidin-3-yl)methyl]carbamoyl}-N-cyclopropyl-2-(naphthalene-2-sulfonamido)propanamido)acetic acid

C26H34N6O6S (558.2260424000001)

Pentatreotide

2-({[10-(4-aminobutyl)-16-benzyl-19-({2-[11-carboxy-4,7,10-tris(carboxymethyl)-2-hydroxy-1,4,7,10-tetraazaundec-1-en-1-yl]-1-hydroxy-3-phenylpropylidene}amino)-6,9,12,15,18-pentahydroxy-7-(1-hydroxyethyl)-13-[(1H-indol-3-yl)methyl]-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaen-4-yl](hydroxy)methylidene}amino)-3-hydroxybutanoate

C63H85N13O20S2 (1407.547497)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D019275 - Radiopharmaceuticals

Pentetoreotide

2-{[2-({[(1-{[10-(4-aminobutyl)-16-benzyl-4-[(1,3-dihydroxybutan-2-yl)-C-hydroxycarbonimidoyl]-6,9,12,15,18-pentahydroxy-7-(1-hydroxyethyl)-13-[(1H-indol-3-yl)methyl]-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaen-19-yl]-C-hydroxycarbonimidoyl}-2-phenylethyl)-C-hydroxycarbonimidoyl]methyl}(carboxymethyl)amino)ethyl]({2-[bis(carboxymethyl)amino]ethyl})amino}acetate

C63H87N13O19S2 (1393.5682312000001)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones